vs

Side-by-side financial comparison of Indivior Pharmaceuticals, Inc. (INDV) and SL GREEN REALTY CORP (SLG). Click either name above to swap in a different company.

Indivior Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($357.0M vs $276.5M, roughly 1.3× SL GREEN REALTY CORP). Indivior Pharmaceuticals, Inc. runs the higher net margin — 28.9% vs -36.5%, a 65.3% gap on every dollar of revenue.

Indivior is a global specialty pharmaceutical company dedicated to developing and commercializing evidence-based treatments for substance use disorders such as opioid use disorder and alcohol dependence, as well as related mental health conditions. Its primary operating markets are North America and Europe, with a portfolio of approved therapies targeting unmet medical needs for underserved patient groups.

SL Green Realty Corp. is a real estate investment trust that primarily invests in office buildings and shopping centers in New York City. As of December 31, 2024, the company owned interests in 39 properties comprising 25,297,353 square feet, primarily in Manhattan. It has been referred to as "New York City’s largest office landlord".

INDV vs SLG — Head-to-Head

Bigger by revenue
INDV
INDV
1.3× larger
INDV
$357.0M
$276.5M
SLG
Higher net margin
INDV
INDV
65.3% more per $
INDV
28.9%
-36.5%
SLG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INDV
INDV
SLG
SLG
Revenue
$357.0M
$276.5M
Net Profit
$103.0M
$-100.8M
Gross Margin
82.1%
Operating Margin
22.7%
64.2%
Net Margin
28.9%
-36.5%
Revenue YoY
12.4%
Net Profit YoY
390.5%
-870.0%
EPS (diluted)
$0.79
$-1.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDV
INDV
SLG
SLG
Q4 25
$357.0M
$276.5M
Q3 25
$314.0M
$244.8M
Q2 25
$302.0M
$241.9M
Q1 25
$266.0M
$239.8M
Q4 24
$245.9M
Q3 24
$307.0M
$229.7M
Q2 24
$299.0M
$222.8M
Q1 24
$187.9M
Net Profit
INDV
INDV
SLG
SLG
Q4 25
$103.0M
$-100.8M
Q3 25
$42.0M
$28.6M
Q2 25
$18.0M
$-7.4M
Q1 25
$47.0M
$-17.3M
Q4 24
$19.1M
Q3 24
$22.0M
$-9.5M
Q2 24
$-97.0M
$1.6M
Q1 24
$16.9M
Gross Margin
INDV
INDV
SLG
SLG
Q4 25
82.1%
Q3 25
73.2%
Q2 25
82.8%
Q1 25
83.1%
Q4 24
Q3 24
78.5%
Q2 24
73.6%
Q1 24
Operating Margin
INDV
INDV
SLG
SLG
Q4 25
22.7%
64.2%
Q3 25
13.7%
85.5%
Q2 25
23.8%
53.4%
Q1 25
24.8%
56.7%
Q4 24
59.8%
Q3 24
11.4%
65.1%
Q2 24
-39.5%
79.2%
Q1 24
Net Margin
INDV
INDV
SLG
SLG
Q4 25
28.9%
-36.5%
Q3 25
13.4%
11.7%
Q2 25
6.0%
-3.0%
Q1 25
17.7%
-7.2%
Q4 24
7.8%
Q3 24
7.2%
-4.2%
Q2 24
-32.4%
0.7%
Q1 24
9.0%
EPS (diluted)
INDV
INDV
SLG
SLG
Q4 25
$0.79
$-1.49
Q3 25
$0.33
$0.34
Q2 25
$0.14
$-0.16
Q1 25
$0.38
$-0.30
Q4 24
$0.13
Q3 24
$0.16
$-0.21
Q2 24
$-0.72
$-0.04
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDV
INDV
SLG
SLG
Cash + ST InvestmentsLiquidity on hand
$195.0M
$155.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-98.0M
$3.7B
Total Assets
$1.2B
$11.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDV
INDV
SLG
SLG
Q4 25
$195.0M
$155.7M
Q3 25
$445.0M
$187.0M
Q2 25
$510.0M
$182.9M
Q1 25
$373.0M
$180.1M
Q4 24
$184.3M
Q3 24
$188.2M
Q2 24
$199.5M
Q1 24
$196.0M
Stockholders' Equity
INDV
INDV
SLG
SLG
Q4 25
$-98.0M
$3.7B
Q3 25
$-207.0M
$3.8B
Q2 25
$-257.0M
$3.8B
Q1 25
$-285.0M
$3.8B
Q4 24
$4.0B
Q3 24
$-310.0M
$3.6B
Q2 24
$-281.0M
$3.7B
Q1 24
$3.7B
Total Assets
INDV
INDV
SLG
SLG
Q4 25
$1.2B
$11.1B
Q3 25
$1.4B
$11.1B
Q2 25
$1.5B
$11.3B
Q1 25
$1.4B
$11.4B
Q4 24
$10.5B
Q3 24
$10.2B
Q2 24
$9.5B
Q1 24
$9.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDV
INDV
SLG
SLG
Operating Cash FlowLast quarter
$-221.0M
$82.9M
Free Cash FlowOCF − Capex
$-245.0M
FCF MarginFCF / Revenue
-68.6%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
-2.15×
TTM Free Cash FlowTrailing 4 quarters
$-93.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDV
INDV
SLG
SLG
Q4 25
$-221.0M
$82.9M
Q3 25
$-39.0M
$-6.8M
Q2 25
$158.0M
$54.5M
Q1 25
$75.0M
$6.7M
Q4 24
$129.6M
Q3 24
$2.0M
$16.7M
Q2 24
$88.0M
$79.4M
Q1 24
$-24.7M
Free Cash Flow
INDV
INDV
SLG
SLG
Q4 25
$-245.0M
Q3 25
$-59.0M
Q2 25
$141.0M
Q1 25
$70.0M
Q4 24
Q3 24
$-5.0M
Q2 24
$84.0M
Q1 24
FCF Margin
INDV
INDV
SLG
SLG
Q4 25
-68.6%
Q3 25
-18.8%
Q2 25
46.7%
Q1 25
26.3%
Q4 24
Q3 24
-1.6%
Q2 24
28.1%
Q1 24
Capex Intensity
INDV
INDV
SLG
SLG
Q4 25
6.7%
Q3 25
6.4%
Q2 25
5.6%
Q1 25
1.9%
Q4 24
Q3 24
2.3%
Q2 24
1.3%
Q1 24
Cash Conversion
INDV
INDV
SLG
SLG
Q4 25
-2.15×
Q3 25
-0.93×
-0.24×
Q2 25
8.78×
Q1 25
1.60×
Q4 24
6.77×
Q3 24
0.09×
Q2 24
50.33×
Q1 24
-1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INDV
INDV

Sublocade$233.0M65%
Sublingual And Other$69.0M19%
Other$49.0M14%
Perseris$6.0M2%

SLG
SLG

Real Estate Segment$223.1M81%
Other$35.9M13%
Debt And Preferred Equity Segment$17.4M6%

Related Comparisons